Methyl(α-methylbenzyl)nitrosamine

Suppliers

Names

[ CAS No. ]:
68690-89-1

[ Name ]:
Methyl(α-methylbenzyl)nitrosamine

[Synonym ]:
Ethylamine,N-methyl-N-nitroso-1-phenyl

Chemical & Physical Properties

[ Density]:
1.02g/cm3

[ Boiling Point ]:
295.3ºC at 760 mmHg

[ Molecular Formula ]:
C9H12N2O

[ Molecular Weight ]:
164.20400

[ Flash Point ]:
132.4ºC

[ Exact Mass ]:
164.09500

[ PSA ]:
32.67000

[ LogP ]:
2.36080

[ Index of Refraction ]:
1.524

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
DP4730000
CHEMICAL NAME :
Benzylamine, alpha,N-dimethyl-N-nitroso-
CAS REGISTRY NUMBER :
68690-89-1
LAST UPDATED :
199612
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C9-H12-N2-O
MOLECULAR WEIGHT :
164.23
WISWESSER LINE NOTATION :
ONN1&Y1&R

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
600 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ZKKOBW Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. Volume(issue)/page/year: 92,235,1978 ** TUMORIGENIC DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
610 mg/kg/59W-C
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Gastrointestinal - tumors
REFERENCE :
ZKKOBW Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. Volume(issue)/page/year: 92,235,1978

Synthetic Route

Click to get detail synthetic route

Related Compounds

  • Methyl α-methylbenzyl ether hydrotrioxide
  • Methyl(α-methylbenzyl)dichlorosilane
  • alpha-methyl-p-methylbenzyl hydroperoxide
  • 1-Methoxy-1-phenylethane
  • Methyl (3S,αR)-(E)-3-[N-benzyl-N-(α-methylbenzyl)amino]hex-4-enoate
  • methyl (3S,αS)-3-[N-(p-methoxybenzyl)-N-(α-methylbenzyl)amino]butyrate
  • N-cyclohexyl-3-(4-fluorophenyl)-5-oxo-4,5-dihydro-[1,2,3]triazolo[1,5-a]quinazoline-8-carboxamide
  • 4-({[2-(3,4-Dimethoxyphenyl)-5-methyl-1,3-oxazol-4-yl]methyl}thio)-2-(2,4-dimethylphenyl)pyrazolo[1,5-a]pyrazine
  • 3,4,5-trimethoxy-N-(4-methoxy-2-phenylquinolin-6-yl)benzamide
  • 1-((3-(3-chlorophenyl)-1,2,4-oxadiazol-5-yl)methyl)-3-(furan-2-ylmethyl)quinazoline-2,4(1H,3H)-dione
  • 1-((3-(2,4-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl)methyl)-3-(3-methoxypropyl)quinazoline-2,4(1H,3H)-dione
  • Methyl 6-chloro-4-[(2-methoxy-5-methylphenyl)amino]quinoline-2-carboxylate
  • Ethyl {[2-(2,5-dimethylphenyl)pyrazolo[1,5-a]pyrazin-4-yl]thio}acetate
  • 4-({[2-(3-Chlorophenyl)-5-methyl-1,3-oxazol-4-yl]methyl}thio)-2-(2,5-dimethylphenyl)pyrazolo[1,5-a]pyrazine
  • 3-(2-methylbenzyl)-6-((3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)methyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-one
  • 3-(3-fluorobenzyl)-6-((3-(2-methoxyphenyl)-1,2,4-oxadiazol-5-yl)methyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-one